Index of artpub/2022/275800/

Montalban, Xavier
Characterisation of the safety profile of evobrutinib in over 1000 patients from phase II clinical trials in multiple sclerosis, rheumatoid arthritis and systemic lupus erythematosus : an integrated safety analysis
2022
https://ddd.uab.cat/record/275800